Pharma IQ Members

Stephen
Kirk

In this latest interview Stephen Kirk, Non-clinical Immunotoxicology, specialist at Covance, speaks to Pharma IQ about what trends will be shaping the field of predictive toxicology over say the next 24 months and how can we deal with anti-drug antibodies. Kirk also discusses the specific toxicology challenges involved in large molecules....Full Article »